HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Lesinurad Impurity N

HCID 178634626
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1533519-99-1
Standard SMILES
O=C(O)CCC(=O)Nc1nnc(SCC(=O)O)n1-c1ccc(C2CC2)c2ccccc12
InChIKey
NDWCXGIQJGYCQC-UHFFFAOYSA-N
Molecular formula
C21H20N4O5S
Average molar mass
440.47 g/mol

Names & identifiers

Preferred name
Lesinurad Impurity N
English name
Lesinurad Impurity N
Molecular formula
C21H20N4O5S
Molecular weight
440.47

Names & synonyms

Lesinurad Impurity Nlesinurad Impurity E: 4-Carboxybutyramide lesinurad4-[[5-(carboxymethylsulfanyl)-4-(4-cyclopropylnaphthalen-1-yl)-1,2,4-triazol-3-yl]amino]-4-oxobutanoic acidButanoic acid, 4-[[5-[(carboxymethyl)thio]-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]amino]-4-oxo-

Database identifiers

CAS
1533519-99-1

Properties

Physicochemical properties

Density
1.56 · 1.56±0.1 g/cm3(Predicted)
pka
2.97 · 2.97±0.10(Predicted)

Chemistry & industry

Applications · 1 item

Uses4-[[5-[(Carboxymethyl)thio]-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]amino]-4-oxo-butanoic Acid is an impurity of drug Lesinurad (L329700), which is used to synthesize febuxostat which is a non-purine analog inhibitor of xanthine oxidase. Febuxostat is approved by the European Medicines Agency and the US Food and Drug Administration for treating gout.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes